EPICS Congress Coverage: ASCO GU 2022 Highlights
Expert perspectives and strategic insights on the latest therapeutic developments in GU malignancies
FACULTY CHAIR
Daniel Petrylak, MD
Yale Cancer Center, New Haven, CT, USA
Faculty Members
Ulka Vaishampayan, MBBS
Rogel Cancer Center, Ann Arbor, MI, USA
Leonard Gomella, MD, FACS
Sidney Kimmel Cancer Center, Philadelphia, PA, USA
Robert Dreicer, MD, MACP, FASCO
University of Virginia Cancer Center, Charlottesville, VA, USA
Oliver Sartor, MD
Tulane Cancer Center, New Orleans, LA, USA
Scott Tagawa, MD, FACP
Weill Cornell Medicine, New York, NY, USA
David Nanus, MD
Weill Cornell Medicine, New York, NY, USA
Karim Fizazi, MD, PhD
Gustave Roussy, Villejuif, France
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
The generated report based on the meeting includes the following topics
- Prostate Cancer Part 1 – Hormonal Therapies and Chemotherapies
- Prostate Cancer Part 2 – Targeted Therapies
- Bladder Cancer Part 1 – ADCs
- Bladder Cancer Part 2 – PARP Inhibitors and Immunotherapies
- Renal Cell Carcinoma
